BCAX · Forms 3, 4, 5
Insider trades at Bicara Therapeutics Inc.
3 insiders sold $1.6M of Bicara Therapeutics Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Bicara Therapeutics Inc. (BCAX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Ryan Cohlhepp | President, COO & Interim CEO | Option exercise | 17,500 | $3.79 | $66K | Form 4 | |
| Ryan Cohlhepp | President, COO & Interim CEO | Sell | 14,058 | $22.77 | $320K | Form 4 | |
| Ryan Cohlhepp | President, COO & Interim CEO | Sell | 3,442 | $23.43 | $81K | Form 4 | |
| Jennifer Larson | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Jennifer Larson | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Ivan Hyep | Chief Financial Officer | Option exercise | 12,500 | $3.79 | $47K | Form 4 | |
| Ivan Hyep | Chief Financial Officer | Sell | 12,500 | $27.97 | $350K | Form 4 | |
| Claire Mazumdar | Chief Executive Officer | Option exercise | 10,000 | $3.79 | $38K | Form 4 | |
| Claire Mazumdar | Chief Executive Officer | Sell | 10,000 | $27.98 | $280K | Form 4 | |
| Ryan Cohlhepp | President and COO | Option exercise | 18,750 | $3.79 | $71K | Form 4 | |
| Ryan Cohlhepp | President and COO | Sell | 18,750 | $27.98 | $525K | Form 4 | |
| Jeremy Bender | Director | Options or other derivatives | Form 4 | ||||
| Christy J. Oliger | Director | Options or other derivatives | Form 4 | ||||
| Jeremy Bender | Director | Became an insider (Form 3) | Form 3 | ||||
| Christy J. Oliger | Director | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.